Approximately 20% of new lung cancer diagnoses occur in nonsmokers in the U.S., according to The Ohio State University ...

With 18.7% of eligible adults reporting being up to date on lung cancer screening in a national survey, this was estimated to ...

New Clinical Trial Site Added for Clinical Studies of Reqorsa® Gene Therapy to Treat Lung Cancer Acclaim-1 and Acclaim-3 ...

The study of the respiratory system microbiome is a burgeoning field that has recently garnered significant attention.

A new report says too few eligible Americans are being checked for the country’s deadliest cancer before it spreads.

A new study published in the journal of BMC Psychiatry showed that adults diagnosed with depression before the age of 16 had ...

Nearly 8% of Ohioans live with chronic obstructive pulmonary disease (COPD), a long-term, progressive lung disease that causes difficulty breathing. In fact, Ohio is among the states in the country ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

Summit Therapeutics' Ivonescimab targets non-small cell lung cancer through its dual anti-PD-1 plus anti-VEGF mechanism.

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...

PRESS RELEASE - Banner Wyoming Medical Center is launching an advanced robotic-assisted bronchoscopy program, becoming a ...

When Sydney Barned was first diagnosed with stage 4 lung cancer, she was just 33 years old — a young medical intern focused ...